fbpx

Metropolis Healthcare Ltd

METP.NS

$21.87

Closing

▲0.60%

1D

▼-9.04%

YTD

METP

BBG001SPC7C9

Exchange

Sector

Market cap

$1.12B

Volume

104,194

Check if the stock is halal

Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.

Get started from just $6.99/month

Market cap

$1.12B

Analysts' Rating

HOLD

Price Target (Mean)

25.51

Total Analysts

16

P/E

65.65

Operating Margin

16.40%

Beta

0.73

Revenue Growth

13.38%

52 week high

$26.84

52 week low

$17.81

Div. Yield

0.43%

EPS Growth

21.87

Company Profile

Metropolis Healthcare Limited is an India-based company, which is engaged in providing diagnostic services patients, healthcare providers, and corporates across India and Africa. The Company has a single operating segment, namely Pathology service. It is mainly engaged in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. The Company serves both the business-to-business (B2B) and business-to-customer (B2C) markets. It has approximately 199 clinical laboratories across 22 states in India. Its subsidiaries include Amin’s Pathology Laboratory Private Limited, Ekopath Metropolis Lab Services Private Limited, Centralab Healthcare Services Private Limited, Metropolis Histoexpert Digital Services Private Limited, among others.